Search

Your search keyword '"Alping, Peter"' showing total 23 results

Search Constraints

Start Over You searched for: Author "Alping, Peter" Remove constraint Author: "Alping, Peter"
23 results on '"Alping, Peter"'

Search Results

1. Comparing the Safety and Effectiveness of Different Medicines to Treat Multiple Sclerosis – The COMBAT-MS Study

2. Validation of the Swedish Multiple Sclerosis registry for pediatric-onset multiple sclerosis.

Catalog

Books, media, physical & digital resources

3. COMBAT‐MS: A Population‐Based Observational Cohort Study Addressing the Benefit–Risk Balance of Multiple Sclerosis Therapies Compared with Rituximab.

4. Hospital‐Treated Infections and Risk of Disability Worsening in Multiple Sclerosis.

10. Multiple sclerosis, disease-modifying drugs and risk for adverse perinatal and pregnancy outcomes: Results from a population-based cohort study

11. sj-docx-1-msj-10.1177_13524585231161492 – Supplemental material for Multiple sclerosis, disease-modifying drugs and risk for adverse perinatal and pregnancy outcomes: Results from a population-based cohort study

12. Pharmacoepidemiological studies of rituximab and other recent therapies in multiple sclerosis

14. Safety of Alemtuzumab and Autologous Hematopoietic Stem Cell Transplantation Compared to Noninduction Therapies for Multiple Sclerosis

16. Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients

17. Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients

18. Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies

19. Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies

21. Rituximab in multiple sclerosis : a retrospective observational study on safety and efficacy

22. Rituximab in multiple sclerosis

23. Reply